Arvinas, Inc.
ARVNNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $479.61M
- P/E (TTM)
- 51.57
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $6.74$14.51
- Volume (live)
- -
- Avg. volume (3M)
- 824.68K
Arvinas (ARVN) Stock Price & Financial Analysis
Arvinas Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.20 - $7.70 |
|---|---|
| 52-Week High | $14.51 |
| 52-Week Low | $6.74 |
| Open | $7.70 |
| Volume (last close) | 651.42K |
| Average Volume (3M) | 824.68K |
| Revenue (TTM) | 316.70M |
|---|---|
| Net Income (TTM) | 9.30M |
| Free Cash Flow (TTM) | -208.80M |
| EPS (TTM) | $0.14 |
| Profit Margin | 2.94% |
| Operating Margin | -4.45% |
| Return on Equity (ROE) | 1.65% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 479.61M |
|---|---|
| Shares Outstanding | 65.70M |
| P/E Ratio (TTM) | 51.57 |
| Price to Sales (P/S) | 1.51 |
| Price to Book (P/B) | 0.85 |
| EV/EBITDA | 1052.76 |
| 50-Day MA | $8.35 |
|---|---|
| 200-Day MA | $9.86 |
| 1-Year Change | −15.72% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Arvinas at a Glance
As of the Oct 23, 2026 close, Arvinas (ARVN) has a market capitalization of $479.61M. The stock trades at 51.6× trailing earnings and 1.5× sales. Over the trailing twelve months it earned $9.30M on revenue of $316.70M (a 2.9% profit margin) and burned $208.80M of free cash flow. Revenue fell 15.1% year over year.
As of its latest reported balance sheet, it holds $94.30M in cash and securities against $8.20M of debt, a net cash position of $86.10M.
Arvinas does not currently pay a dividend.
The share price is down 15.7% over the past year. At $7.30 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $6.74 to $14.51, below its 200-day moving average of $9.86.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $15.07, 106.4% above the Oct 23, 2026 close.
Frequently Asked Questions About Arvinas
What is the current stock price for ARVN?
As of the Oct 23, 2026 close, ARVN stock trades at $7.30. The 52-week range is $6.74–$14.51, with a day range of $7.20–$7.70.
What is the P/E ratio for ARVN?
As of the Oct 23, 2026 close, Arvinas's trailing twelve-month (TTM) P/E ratio is 51.6, meaning investors pay $51.6 for every $1 of annual earnings. Arvinas operates in the Healthcare sector.
Does ARVN pay dividends?
Arvinas does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ARVN?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for ARVN is Buy. The average 12-month price target is $15.07, a 106.4% upside from the Oct 23, 2026 close of $7.30.
What is the market cap of ARVN?
As of the Oct 23, 2026 close, Arvinas's market capitalization is $479.6M, classifying it as a small-cap company. Arvinas operates in the Healthcare sector within the Biotechnology industry.